Our CEO & Co-Founder, Dr. Colleen Cutcliffe, PhD, was interviewed by The Washington Post about Akkermansia and its promising role in boosting the microbiome. We know it’s a game-changer for those looking to improve gut and metabolic health! Find out what differentiates Akkermansia from other probiotic strains on the market: https://lnkd.in/dAEmCYuZ #HealthNews #GutHealth #Microbiome #Probiotics #Akkermansia
Pendulum Therapeutics
Biotechnology
San Francisco, California 6,820 followers
Reinventing Health Through the Microbiome
About us
Pendulum is committed to developing novel interventions that target the human microbiome to improve the lives of patients suffering from a variety of diseases. Our targeted formulations of natural bacterial strains help to rebalance the microbiome which restores and improve one’s health.
- Website
-
http://pendulum.co
External link for Pendulum Therapeutics
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2012
Locations
-
Primary
953 Indiana St
San Francisco, California 94107, US
Employees at Pendulum Therapeutics
Updates
-
Pendulum Therapeutics is currently enrolling athletes in our newest consumer research opportunity! We're investigating the impact of a three-strain probiotic on athletic performance. 🚀Join us in advancing science—take our 10-minute survey to see if you qualify and receive free probiotics! 🔗Enroll now: https://lnkd.in/gxwNUkaW
Attention athletes: Did you know your gut microbiome could be the key to unlocking peak performance? Pendulum Therapeutics is conducting innovative athlete microbiome research on a three-strain probiotic with the potential to impact athletic performance. They’re looking for participants to join this groundbreaking opportunity. Interested in contributing to cutting-edge science and potentially enhancing your performance? Take this quick 10-minute survey to see if you qualify and receive free probiotics: https://bit.ly/3X1gevr
-
-
Calling all PharmD’s! Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health. Learn from Kara Siedman RD, CDCES about the latest research uncovering the impact of A.muciniphila, C.butyricum, B.infantis and other novel strains on GLP-1 signaling, satiety, cravings, and probiotic avenues for metabolic disorders. Register now: https://lnkd.in/ggefYu-x
-
-
At Pendulum, we're dedicated to pioneering microbiome research to unravel the mysteries of the gut and its profound impact on human health. As part of this commitment we launched a new clinical study in collaboration with BiomeSense. Focusing on one of the microbiome’s keystone strains, Akkermansia muciniphila, the study will utilize BiomeSense’s cutting-edge GutLab™ device to continuously sample and analyze stool microbiome data, providing unprecedented insights into the microbiome's composition over time. Read the press release here: https://bit.ly/3XkU3ll To learn more about this study and other research that Pendulum is involved in, go to https://lnkd.in/gRFPZJU9
Pendulum Therapeutics and BiomeSense launch pioneering study on gut microbiome using continuous sampling technology
eurekalert.org
-
Tune in to hear Adam Perlman, MD, MPH discuss the importance of gut health, the revolutionary science behind Pendulum products, and the future of personalized probiotics on The American Academy of Anti-Aging Medicine (A4M)'s Redefining Medicine podcast! Listen now: https://lnkd.in/dER7rd2S
-
-
Join Integrative Practitioner and Adam Perlman, MD, MPH as he dives deep into the latest research on how Akkermansia muciniphila, Clostridium butyricum, Bifidobacterium infantis, and other novel strains influence satiety, cravings, and metabolic disorders. Integrative healthcare practitioners won't want to miss this webinar exploring the groundbreaking connection between Akkermansia and GLP-1, a hormone critical for regulating metabolism. Register now: https://shorturl.at/G5iKk
-
-
Join Sharon H., MD, Chief Medical Officer for IntellxxDNA®, and Christina O'Connor, RD, for a fascinating discussion on the potential of next-generation probiotics. Learn how Akkermansia muciniphila and Clostridium butyricum may play a role in supporting overall health, potentially modulating the effects of specific genetic variations linked to: Diabetes, obesity, inflammatory conditions, and autoimmune disorders. This session will explore the future of personalized gut health solutions and their potential impact on managing complex conditions. Register now: https://shorturl.at/NTm5g
-
-
You’re invited to unlock the secrets of the gut microbiome at our sponsored lunch at #IFMAIC2024 on May 31st. Pendulum Co-Founder & CEO Colleen Cutcliffe, will be joined by award-winning actor and Pendulum Chief Communications Officer, Halle Berry, and Dr. Kara Fitzgerald ND, IFMCP, to discuss how Akkermansia and other next-generation strains optimize the power of the gut microbiome to improve metabolic health.
-
-
Join us for the next installment of our Spring Speaker Series featuring Julie Greenberg, ND, RH(AHG), MBA discussing the research linking the gut microbiome and chronic dermatological issues, the role Akkermansia muciniphila plays in the gut/skin axis, and case studies demonstrating the effective treatment of acne by addressing the gut microbiome. Register now: https://shorturl.at/O1MIT
-
-
Join microbiome and diabetes expert, Orville Kolterman, MD, and summit host Dr. Beverly Yates, ND for an in-depth interview on how the microbiome influences glucose management. - The pathophysiological changes that occur in the gut microbiome linking gut health and metabolic syndrome - The beneficial functions of certain gut bacterial strains that may be deficient in people with type 2 diabetes - The mechanisms through which probiotic strains such as A. muciniphila and C. butyricum induce downstream GLP-1 production - The science and evidence for the use of a synbiotic formulated to improve gut health and assist with glycemic management in people with type 2 diabetes Register now: https://shorturl.at/tzHRT
-